Clinical Trials Directory

Trials / Unknown

UnknownNCT06108401

Effect Of a Goat Milk-Based Infant Formula On Gastrointestinal And Other Symptoms And Health-Related Quality Of Life.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
152 (estimated)
Sponsor
Medical University of Warsaw · Academic / Other
Sex
All
Age
14 Days – 90 Days
Healthy volunteers
Accepted

Summary

In this trial, the investigators aim to assess impact of goat milk-based infant formula on the severity and frequency of gastrointestinal symptoms, as well as other associated symptoms, and the health-related quality of life in infants exhibiting symptoms possibly related to cow's milk, compared to a cow milk-based formula.

Detailed description

Gastrointestinal symptoms are frequent in the first 6 months of life in otherwise healthy infants fed cow milk-based infant formulas (CMF). In management special infant formulas may be considered, although none is routinely recommended. Goat milk-based infant formulas (GMF) have shown promising effects on digestion and increased gastric emptying in several in vitro studies. In this trial, a total of 158 participants at age 14 to 90 days, who exhibit gastrointestinal and/or other symptoms associated with CMF consumption, as assessed with the Cow's Milk-related Symptom Score (CoMiSS) between 6 and 10 will be randomly allocated to GMF or CMF for four weeks. The primary outcome will be the proportion of infants showing a reduction of at least 4 points in CoMiSS following the four-week intervention period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGoat milk-based infant formulaGoat milk-based infant formula exclusively for 4 weeks at a volume depending on the infant.
DIETARY_SUPPLEMENTCow milk-based infant formulaRegular cow milk-based infant formula that is similar in color, smell, and taste to the formula received by the experimental group.

Timeline

Start date
2023-11-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2023-10-31
Last updated
2023-10-31

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06108401. Inclusion in this directory is not an endorsement.